The ASGE recommends screening for pancreatic cancer starting at age 50 or in patients with an ATM mutation and first- or second-degree relatives with a pancreatic cancer history 10 years younger than the youngest relative with pancreatic cancer, which is similar to the AGA and CAPS [16,77,78]. The gene discussed is ATM; the disease is pancreatic neoplasm.